journal article·2018-11-05Open access

Highly stable gold nanoparticles green-synthesized by upcycling cartilage waste extract from yellow-nose skate (Dipturus chilensis) and evaluation of its cytotoxicity, haemocompatibility and antioxidant activity

Eun-Young Ahn, You Jeong Lee, Seo Young Choi, A-Rang Im, Yeong Shik Kim, Youmie Park

Abstract

Skate (Dipturus chilensis) cartilage extract was utilized as a green reducing agent for the synthesis of spherical gold nanoparticles with an average size of 16.7 ± 0.2 nm. The gold nanoparticle solution showed a surface plasmon resonance at 543 nm with a wine-red colour. A strong X-ray diffraction pattern and clear lattice structure in high-resolution transmission electron microscopy indicated a face-centred cubic structure of the gold nanoparticles. The gold nanoparticles retained excellent colloidal stability. Gold nanoparticles showed strong antioxidant activity in terms of 2,2-diphenyl-1-picrylhydrazyl radical scavenging activity. In vitro cytotoxicity was observed for seven cancer cells assessed by the water-soluble tetrazolium assay. Among the seven cancer cells, the highest cytotoxicity was observed for MDA-MB-231 (human breast adenocarcinoma cell) followed by HeLa (human epithelial cervix adenocarcinoma cell) and lastly by HT-29 (human colorectal adenocarcinoma cell). Furthermore, gold nanoparticles showed excellent haemocompatibility, indicating the possibility of their use as a future nanomedicine. These results strongly suggest that gold nanoparticles green-synthesized by upcycling skate cartilage waste extract will be valuable carriers or vehicles for the delivery of drugs or bioactive molecules, such as anti-cancer agents, for the treatment of cancers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gyeongnam, Republic of Korea;

KM Convergence Research Division, Korea Institute of Oriental Medicine, Yuseong-gu Daejeon, Republic of Korea;

College of Pharmacy and Natural Products Research Institute, Seoul National University, Seoul, Republic of Korea

Funding

National Research Foundation of Korea

References (43)

Show source-provided references
1. 10.1016/j.biotechadv.2013.01.00310.1016/j.biotechadv.2013.01.003 ↗
2. 10.1080/21691401.2016.124179210.1080/21691401.2016.1241792 ↗
3. 10.5487/TR.2014.30.3.16910.5487/TR.2014.30.3.169 ↗
4. 10.1021/sc300118u10.1021/sc300118u ↗
5. 10.3109/21691401.2014.95510710.3109/21691401.2014.955107 ↗
6. 10.1021/acs.jpcc.5b1123210.1021/acs.jpcc.5b11232 ↗
7. 10.1088/1361-6579/aa718210.1088/1361-6579/aa7182 ↗
8. 10.1039/C6RA04433F10.1039/C6RA04433F ↗
9. 10.1016/j.snb.2016.06.08110.1016/j.snb.2016.06.081 ↗
10. 10.1080/21691401.2016.117813410.1080/21691401.2016.1178134 ↗
11. 10.1002/adma.20160589710.1002/adma.201605897 ↗
12. 10.1049/iet-nbt.2010.003310.1049/iet-nbt.2010.0033 ↗
13. 10.1166/jnn.2012.657510.1166/jnn.2012.6575 ↗
14. 10.1002/ptr.368310.1002/ptr.3683 ↗
15. 10.1166/jnn.2014.888110.1166/jnn.2014.8881 ↗
16. 10.1166/jnn.2015.903110.1166/jnn.2015.9031 ↗
17. 10.1166/jnn.2015.1020410.1166/jnn.2015.10204 ↗
18. 10.1166/jnn.2018.1521010.1166/jnn.2018.15210 ↗
19. Lee YJ · Nat Prod Commun · 2015 · 10 · 1593
20. 10.2147/IJN.S14019010.2147/IJN.S140190 ↗
21. Han L · Nat Prod Commun · 2013 · 8 · 1149
22. 10.1016/j.msec.2015.09.06810.1016/j.msec.2015.09.068 ↗
23. 10.1007/s12272-016-0718-810.1007/s12272-016-0718-8 ↗
24. 10.1166/jnn.2018.1438910.1166/jnn.2018.14389 ↗
25. 10.1166/jnn.2018.1398210.1166/jnn.2018.13982 ↗
26. 10.1186/s11671-016-1776-z10.1186/s11671-016-1776-z ↗
27. 10.1166/jnn.2013.749210.1166/jnn.2013.7492 ↗
28. 10.1007/s11051-016-3466-210.1007/s11051-016-3466-2 ↗
29. 10.1186/1556-276X-9-10310.1186/1556-276X-9-103 ↗
30. 10.1166/jnn.2013.690610.1166/jnn.2013.6906 ↗
31. 10.1088/0957-4484/24/39/39510210.1088/0957-4484/24/39/395102 ↗
32. 10.1016/j.ijbiomac.2013.10.02610.1016/j.ijbiomac.2013.10.026 ↗
33. 10.1166/jnn.2012.616910.1166/jnn.2012.6169 ↗
34. 10.1016/j.matlet.2014.05.03210.1016/j.matlet.2014.05.032 ↗
35. 10.1166/jnn.2016.1239310.1166/jnn.2016.12393 ↗
36. 10.1166/jnn.2017.1344310.1166/jnn.2017.13443 ↗
37. Im AR · Food Sci Biotechnol · 2009 · 18 · 872
38. 10.1007/s13197-011-0440-y10.1007/s13197-011-0440-y ↗
39. 10.1007/s10924-017-1129-810.1007/s10924-017-1129-8 ↗
40. Sanna V · Int J Nanomed · 2014 · 9 · 4935
41. Patra JK · Int J Nanomed · 2015 · 10 · 7253
42. 10.1186/s11671-017-1833-210.1186/s11671-017-1833-2 ↗
43. 10.1039/c4nr01234h10.1039/c4nr01234h ↗